Paper3923027
Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
Styne DM and 7 others. J Clin Endocrinol Metab, 1985. Cited by 106 papers, by iCite.
Cite this record
ConductScience Library. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis. Papers, record 3923027. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3923027
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gonadotropin-Releasing Hormone | Major topic |
| Hypothalamo-Hypophyseal System | Major topic |
| Ovary | Major topic |
| Puberty, Precocious | Major topic |
| Testis | Major topic |
| Triptorelin Pamoate | Major topic |
| Age Determination by Skeleton | |
| Child | |
| Child, Preschool | |
| Estradiol | |
| Female | |
| Follicle Stimulating Hormone | |
| Growth | |
| Humans | |
| Infant | |
| Luteinizing Hormone | |
| Male | |
| Sex Characteristics | |
| Sexual Maturation | |
| Testosterone | |
| Ultrasonics | |
| Uterus |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RR-01271 | NCRR NIH HHS | United States | M01RR001271 | PubMed and NIH |
Source NIH RePORTER
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 106 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32738042 | Phase 3 Trial of a Small-volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty. | J Clin Endocrinol Metab | 2020 | https://conductscience.org/library/papers/32738042 | PubMed |
| 28591479 | Hypothalamic hamartoma with epilepsy: Review of endocrine comorbidity. | Epilepsia | 2017 | https://conductscience.org/library/papers/28591479 | PubMed |
| 8748879 | A super long-acting LH-RH analogue induces regression of hypothalamic hamartoma associated with precocious puberty. | Acta Neurochir (Wien) | 1995 | https://conductscience.org/library/papers/8748879 | PubMed |
| 7699213 | Precocious puberty: auxological criteria discriminating different forms. | J Endocrinol Invest | 1994 | https://conductscience.org/library/papers/7699213 | PubMed |
| 7684676 | Histrelin. A review of its pharmacological properties and therapeutic role in central precocious puberty. | Drugs | 1993 | https://conductscience.org/library/papers/7684676 | PubMed |
| 7629394 | Usefulness of early morning urine estrone-3-glucuronide assay in the monitoring ovarian secretory function in precocious puberty. | J Endocrinol Invest | 1995 | https://conductscience.org/library/papers/7629394 | PubMed |
| 3759187 | Management of precocious puberty. | Indian J Pediatr | 1986 | https://conductscience.org/library/papers/3759187 | PubMed |
| 3278879 | GnRH agonists and antagonists. Current clinical status. | Drugs | 1988 | https://conductscience.org/library/papers/3278879 | PubMed |
| 3123239 | Treatment of central precocious puberty with an intranasal analogue of GnRH (Buserelin). | Eur J Pediatr | 1987 | https://conductscience.org/library/papers/3123239 | PubMed |
| 3109919 | The effect of treatment with an LH-RH agonist (Buserelin) on gonadal activity growth and bone maturation in children with central precocious puberty. | Eur J Pediatr | 1987 | https://conductscience.org/library/papers/3109919 | PubMed |
| 2960531 | The effect of cyproterone acetate on the growth of children with central precocious puberty. | Eur J Pediatr | 1987 | https://conductscience.org/library/papers/2960531 | PubMed |
| 2782932 | Precocious puberty in girls: early diagnosis of a slowly progressing variant. | Arch Dis Child | 1989 | https://conductscience.org/library/papers/2782932 | PubMed |
| 2138079 | Treatment of children with central precocious puberty by a slow-release gonadotropin-releasing hormone agonist. | Eur J Pediatr | 1990 | https://conductscience.org/library/papers/2138079 | PubMed |
| 1712706 | Drug treatment in precocious puberty. | Drugs | 1991 | https://conductscience.org/library/papers/1712706 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GNRH1 | 2796 | PubTator's text mining | https://conductscience.org/library/genes/2796 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3923027
GET https://conductscience.org/api/papers/v1/3923027/authors